Table 2. [Part 2]. Description of Studies in Eastern Mediterranean Region Office (EMRO) and Middle Eastern Countries That Met Our Eligibility Criteria.
| Country | Pub. year | Male, % | Sample Size | HBsAg Prevalence (95% CI) |
|---|---|---|---|---|
| Iraq (E and M) | ||||
| Al-Juboury, A. | 2010 | 99 | 23,336 | 0.73 (0.62 – 0.83) |
| Ataallah, T. M. | 2011 | 97 | 495,648 | 0.66 (0.63 – 0.68) |
| Jordan (E and M) | ||||
| Al-Rashed, M. | 2003 | 93 | 18,000 | 1.72 (1.53 – 1.9) |
| Kuwait (E and M) | ||||
| Ameen, R. | 2005 | NR | 12,798 | 1.92 (1.68 – 2.15) |
| Lebanon (E and M) | ||||
| Irani-Hakime, N. | 2006 | 93 | 16,084 | 0.92 (0.77 – 1.07) |
| Morocco (E) | ||||
| Baha, W. | 2013 | 79 | 169,605 | 0.95 (0.9 – 0.99) |
| Pakistan (E) | ||||
| Akhtar, S. | 2005 | 100 | 351,309 | 2 (1.95 – 2.04) |
| Asif, N. | 2004 | NR | 3,430 | 2.4 (1.89 – 2.91) |
| Attaullah, S. | 2012 | NR | 127,828 | 2.68 (2.59 – 2.76) |
| Bangash, M. H. | 2009 | NR | 1,300 | 5.07 (3.89 – 6.24) |
| Bhatti, F. A. | 2007 | NR | 94,177 | 2.16 (2.06 – 2.25) |
| Chaudhry, M. A. | 2013 | 95 | 2,155 | 1.34 (0.87 – 1.81) |
| Farooqi, J. I. | 2007 | NR | 166,189 | 2.54 (2.46 – 2.61) |
| Ijaz, R. | 2012 | NR | 3,652 | 4 (3.37 – 4.62) |
| Khan, N. U. | 2010 | NR | 7,148 | 2.05 (1.71 – 2.38) |
| Khattak, M. F. | 2002 | NR | 103,858 | 3.31 (3.2 – 3.41) |
| Abdul Mujeeb, S. | 2008 | 99 | 5,345 | 6.2 (5.55 – 6.84) |
| Abdul Mujeeb, S. | 2006 | 98 | 7,325 | 4.7 (4.23 – 5.17) |
| Zaheer, H. A. | 2014 | 99.6 | 160,376 | 2.35 (2.27 – 2.42) |
| Rahman, M. U. | 2002 | NR | 1,021,505 | 2.25 (2.22 – 2.27) |
Abbreviations: E, EMRO countries; E and M, all countries from the two regions; M, middle eastern countries; NR, not reported.